NCT00349856

Brief Summary

The purpose of the study is to evaluate the fit and performance of an investigational soft contact lens in comparison with a currently marketed lens. Both lenses will be worn on a continuous wear basis, which means the lenses will be worn while sleeping.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Jan 2005

Typical duration for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2005

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

July 5, 2006

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 10, 2006

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2008

Completed
Last Updated

February 18, 2009

Status Verified

February 1, 2009

Enrollment Period

3.2 years

First QC Date

July 5, 2006

Last Update Submit

February 17, 2009

Conditions

Outcome Measures

Primary Outcomes (1)

  • The primary objective of this trial is to assess safety of the investigational

    study visits, three monthly

Secondary Outcomes (1)

  • The secondary objective of this trial is to assess the subjective responses to comfort with both the investigational and marketed lenses.

    study visits, three monthly

Study Arms (1)

1

ACTIVE COMPARATOR
Device: Biofinity

Interventions

BiofinityDEVICE

Soft contact lens

Also known as: Purevision
1

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Has had an oculo-visual examination in the last 2 years.
  • Is between 18-45 years old and has full legal capacity to volunteer.
  • Has read and understood the Information Consent Letter
  • Is willing and able to follow participant instructions for product usage and meet the protocol-specified schedule of follow-up visits.
  • Is correctable with the prescription of the available lenses (-1.00 to -4.00 DS in 0.50D step).
  • Is correctable to at least 20/40 distance visual acuity with contact lenses in each eye.
  • Is a current soft contact lens wearer (both daily wear and extended wear experience allowed).
  • Has refractive astigmatism of \<= 1.00 diopters
  • Has clear corneas and ocular clinical findings considered to be "normal".

You may not qualify if:

  • Has any systemic disease affecting ocular health.
  • Is using any systemic or topical medications that will affect ocular health.
  • Has any ocular pathology or severe insufficiency of lacrimal secretion (dry eyes) that would affect the wearing of contact lenses.
  • Has any clinically significant lid or conjunctival abnormalities, neovascularization, corneal scars or corneal opacities.
  • Has limbal injection, bulbar injection or corneal staining that, in the Investigator's opinion, is clinically significant.
  • Has never worn contact lenses before.
  • Has corneal distortion resulting from rigid lens wear.
  • Is aphakic.
  • Has undergone corneal refractive surgery.
  • Is participating in any other type of clinical or research study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre for Contact Lens Research, University of Waterloo

Waterloo, Ontario, N2L3G1, Canada

Location

MeSH Terms

Conditions

Myopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Study Officials

  • Desmond Fonn, MOptom

    Centre for Contact Lens Research, University of Waterloo.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

July 5, 2006

First Posted

July 10, 2006

Study Start

January 1, 2005

Primary Completion

March 1, 2008

Study Completion

March 1, 2008

Last Updated

February 18, 2009

Record last verified: 2009-02

Locations